Member access

4-Traders Homepage  >  Shares  >  Xetra  >  CytoTools AG    T5O   DE000A0KFRJ1

CYTOTOOLS AG (T5O)

7
End-of-day quote. End-of-day quote Xetra - 09/15
54 EUR   -0.33%
07/25 CYTOTOOLS : Clinical development
07/25 CYTOTOOLS : Clinical development of wound healing drug DermaPro(R) progress..
07/23 CYTOTOOLS : Annual General Meeting 2014
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Xetra
09/09/2014 09/10/2014 09/11/2014 09/12/2014 09/15/2014 Date
53.03(c) 52.89(c) 53.5(c) 54.18(c) 54(c) Last
932 328 550 236 234 Volume
-1.81% -0.26% +1.15% +1.27% -0.33% Change
More quotes
Company
CytoTools AG operates as a technology and associated company, which is engaged in the purchase, management and sale of shareholdings in German technology enterprises. It focuses on investing in enterprises from the health sector, active in the area of research and development of medicaments and... 
More about the company
Chart CYTOTOOLS AG
Duration : Period :
CytoTools AG Technical Analysis Chart | T5O | DE000A0KFRJ1 | 4-Traders
Full-screen chart
Financials (€)
Sales 2014 1,03 M
EBIT 2014 -0,74 M
Net income 2014 -0,90 M
Finance 2014 2,50 M
Yield 2014 -
Sales 2015 6,26 M
EBIT 2015 3,04 M
Net income 2015 1,16 M
Finance 2015 2,00 M
Yield 2015 -
PER 2014 -
PER 2015 90,30
EV / Sales 2014 98,0x
EV / Sales 2015 16,1x
Capitalization 103 M
More Financials
Latest news on CYTOTOOLS AG
07/25 CYTOTOOLS : Clinical development
07/25 CYTOTOOLS : Clinical development of wound healing drug DermaPro(R) progressing o..
07/23 CYTOTOOLS : Annual General Meeting 2014
07/23 CYTOTOOLS : Annual General Meeting elects new Supervisory Board members (DGAP Ne..
06/23 CYTOTOOLS : Capital Increase CytoPharma GmbH
06/23 CYTOTOOLS : adds cardiovascular and further indications to its field of interest..
04/28 CYTOTOOLS : strengthens successful subsidiary DermaTools Biotech GmbH with furth..
04/22 CYTOTOOLS : Strategic move for a successful market launch of DermaPro
2013 CYTOTOOLS AG : Market authorization application submitted for DermaPro® in India
2013 CYTOTOOLS AG : announces the first order for the manufacture of DermaPro® for th..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Technical analysis
Income Statement Evolution
CytoTools AG : Income Statement Evolution
More Financials
EPS Revisions
CytoTools AG : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF